234
Views
26
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Impact of Psychiatric Comorbidity on the In-Treatment Outcomes of Cocaine-Dependent Patients in Therapeutic Communities

, PhD, , PhD, , PhD, , PhD & , PhD

REFERENCES

  • European Monitoring Centre for Drugs and Drug Addiction. (2012). Annual Report 2012: Annual report on the state of the drugs problem in Europe. Available at: http://www.emcdda.europa.eu/publications/annual-report/2012.
  • Malivert M, Fatséas M, Denis C, Langlois E, Auriacombe M. Effectiveness of therapeutic communities: a systematic review. Eur Addict Res. 2012;18:1–11.
  • Condelli WS, Hubbard RL. Relationship between time spent in treatment and client outcomes from therapeutic communities. J Subst Abuse Treat. 1994;11:25–33.
  • Condelli WS, De Leon GD. Fixed and dynamic predictors of client retention in therapeutic communities. J Subst Abuse Treat. 1993;10:11–16.
  • Messina N, Wish E, Nemes, S. Predictors of treatment outcomes in men and women admitted to a therapeutic community. Am J Drug Alcohol Abuse. 2000;26:207–227.
  • Messina N, Wish E, Nemes S. Therapeutic community treatment for substance abusers with antisocial personality disorder. J Subst Abuse Treat. 1999;17:121–128.
  • Levin FR, Evans SM, Vosburg SK, Horton T, Brooks D, Ng J. Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addict Behav. 2004;29:1875–1882.
  • Wise BK, Cuffe SP, Fischer T. Dual diagnosis and successful participation of adolescents in substance abuse treatment. J Subst Abuse Treat. 2001;21:161–165.
  • Vergara-Moragues E, González-Saiz F, Lozano Rojas O, et al. Psychiatric comorbidity in cocaine users treated in therapeutic community: substance-induced versus independent disorders. Psychiatry Res. 2012;200:734–741.
  • Mulder R, Frampton CM, Peka H, Hampton G, Marsters T. Predictors of 3-month retention in a drug treatment therapeutic community. Drug Alcohol Rev. 2009;28:366–371.
  • Sacks S, McKendrick K, Sacks JY, Cleland CM. Modified therapeutic community for co-occurring disorders: single investigator meta analysis. Subst Abus. 2010;31:146–161.
  • Darke S, Campbell G, Popple G. Retention, early dropout and treatment completion among therapeutic community admissions. Drug Alcohol Rev. 2012;31:64–71.
  • Kaminer Y, Tarter RE, Bukstein OG, Kabene M. Comparison between treatment completers and noncompleters among dually diagnosed substance-abusing adolescents. J Am Acad Child Adolesc Psychiatry. 1992;31:1046–1049.
  • Broome KM, Flynn PM, Simpson DD. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. HSR. 1999;34:791–806.
  • Stowell RJ, Estroff TW. Psychiatric disorders in substance-abusing adolescent inpatients: a pilot study. J Am Acad Child Adolesc Psychiatry. 1992;31(6):1036–1040.
  • Agostini V, Nunes E, Stewart JW, Quitkin FM. Patient factors related to early attrition from an outpatient cocaine research clinic: a preliminary report. Int J Addict. 1991;26:327–334.
  • Alterman AI, Rutherford MJ, Cacciola JS, McKay JR, Woody GE. Response to methadone maintenance and counseling in antisocial patients with and without major depression. J Nerv Ment Dis. 1996;184:695–670.
  • Dekel R, Benbenishty R, Amram Y. Therapeutic communities for drug addicts: prediction of long-term outcomes. Addict Behav. 2004;29:1833–1837.
  • Sacks S, De Leon G, Sacks JY, McKendrick K, Brown BS. TC-oriented supported housing for homeless MICAs. J Psychoactive Drugs. 2003;35:355–366.
  • Skinner DC. A modified therapeutic community for homeless persons with co-ocurring disorders of substance abuse and mental illness in a shelter: an outcome study. Subst Use Misuse. 2005;40:483–497.
  • Jainchill N, Hawke J, Messina M. Post-treatment outcomes among adjudicated adolescent males and females in modified therapeutic community treatment. Subst Use Misuse. 2005;40:975–996.
  • McLellan AT. Have we evaluated addiction treatment correctly? Implications from a chronic care perspective. Addiction. 2002;97:249–252.
  • Greenberg B, Hall DH, Sorensen JL. Methadone maintenance therapy in residential therapeutic community settings: challenges and promise. J Psychoactive Drugs. 2007;39:203–210.
  • De Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res. 2005;76:135–157.
  • Simpson DD. A conceptual framework for drug treatment process and outcomes. J Subst Abuse Treat. 2004;27:99–121.
  • Simpson DD. Modeling treatment process and outcomes. Addiction. 2001;96(2):207–211.
  • Sells SB, Simpson DD, Joe GW, Demaree RG, Savage LJ, Lloyd MR. A national follow-up study to evaluate the effectiveness of drug abuse treatment: a report on cohort 1 of the DARP five years later. Am J Drug Alcohol Abuse. 1976;3:545–556.
  • Hser Y. Predicting long-term stable recovery from heroin addiction: findings from a 33-year follow-up. J Addict Dis. 2007;26:51–60.
  • De Leon G. The therapeutic community for substance abuse: perspective and approach. In: De Leon G, Ziegenfuss JT, eds. Therapeutic Communities for Addictions. . Charles C. Thomas: Springfield, IL; 1986.
  • Orlando M, Wenzel SL, Ebener P, Edwards MC, Mandell W, Becker K. The dimensions of change in therapeutic community treatment instrument. Psychol Assesst. 2006;18:118–122.
  • Arenas F, del Valle M, López R, Martín J, Tirado P. Programa de intervención. comunidad terapéutica en Andalucía. Seville: Consejería de asuntos sociales. Comisionado para las drogodependencias, Junta de Andalucía; 2003.
  • Ariza MJ, Arenas F, Coords. . 2012. Protocolo de actuación conjunta unidades de salud mental comunitaria y centros de tratamiento ambulatorio de drogodependencias. Andalucia, Spain: Servicio Andaluz de Salud, Consejería de Salud, Junta de Andalucía; 2012.
  • Torrens M, Serrano D, Astals M, Perez-Dominguez G, Martin-Santos R. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. Am J Psychiatry. 2004;161:1231–1237.
  • Hasin D, Samet S, Nunes E, Meydan J, Matseoane K, Waxman R. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am J Psychiatry. 2006;163:689–696.
  • Morgello S, Holze CE 3rd, Ryan E, et al. Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: experience of the National NeuroAIDS Tissue Consortium. Int J Methods Psychiatr Res. 2006;15:131–138.
  • Condelli WS, Hubbard RL. Client outcomes from therapeutic communities. In: Tims FM, De Leon G, Jainchill N, eds. Therapeutic Community: Advances in Research and Application. . NIDA Research Monograph 144. 1994.
  • Lewis BJ, Ross R. Retention in therapeutic communities: challenges for the nineties. In: Tims FM, De Leon G, Jainchill N, eds. Therapeutic Community: Advances in Research and Application. . NIDA Research Monograph 144. 1994.
  • Daughters SB, Lejuez CW, Bornovalova MA, Kahler CW, Strong DR. Brown RA. Distress tolerance as a predictor of early treatment dropout in a residential substance abuse treatment facility. J Abnormal Psychol. 2005;114:729–734.
  • Tull M, Gratz KL. The impact of borderline personality disorder on residential substance abuse treatment dropout among men. Drug Alcohol Depend. 2012;121:97–102.
  • Lejuez CW, Zvolensky MJ, Daughters SB, et al. Anxiety sensitivity: a unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment. Behav Res Ther. 2008;46:811–818.
  • Halikas JA, Crosby R, Pearson V, Nugent S, Carlson G. Psychiatric comorbidity in treatment-seeking cocaine abusers. Am J Addict. 1994;3(1):25–35.
  • Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry. 1991;48:43–51.
  • Vergara-Moragues E, González-Saiz F, Lozano OM, Verdejo-García A. Psychiatric profile of three-month retention in cocaine-dependent patients treated in a therapeutic community. J Stud Alcohol Drug. 2013;74:452–459.
  • Vergara-Moragues E, González-Saiz F, Lozano Rojas O, et al. Diagnosing adult attention deficit/hyperactivity disorder in patients with cocaine dependence: discriminant validity of Barkley executive dysfunction symptoms. Eur Addict Res. 2011;17:279–284.
  • Herrero MJ, Domingo-Salvany A, Brugal MT, Torrens M, Itinere Investigators. Incidence of psychopathology in a cohort of young heroin and/or cocaine users. J Subst Abuse Treat. 2011;41:55–63.
  • Fernández-Hermida JR, Secades-Villa R, Fernández-Ludeña JJ, Marina-González PA. Effectiveness of a therapeutic community treatment in Spain: a long-term follow-up study. Eur Addict Res. 2002;8:22–29.
  • Secades Villa R, Benavente M. Predictores de la retención en una comunidad terapéutica para drogodependientes. Adicciones. 2000;12:365–371.
  • Stark MJ. Dropping out of substance abuse treatment: a clinically oriented review. Clin Psychol Rev. 1992;12:93–116.
  • Condelli WS, De Leon GD. Fixed and dynamic predictors of client retention in therapeutic communities. J Subst Abuse Treat. 1993;10:11–16.
  • Nielsen AL, Scarpitti FR. Predicting retention in a therapeutic community for incarcerated substance abusers. J Offender Rehabil. 2002;34:47–65.
  • Van Stelle KR, Blumer C, Moberg DP. Treatment retention of dually diagnosed offenders in an institutional therapeutic community. Behav Sci Law. 2004;22:585–597.
  • McGeary KA, French MT, Sacks S, McKendrick K, De Leon, G. Service use and cost by mentally ill chemical abusers: differences by retention in a therapeutic community. J Subst Abuse. 2000;11:265–279.
  • Falck RS, Wang J, Siegal HA, Carlson RG. The prevalence of psychiatric disorder among a community sample of crack cocaine users: an exploratory study with practical implications. J Nerv Ment Dis. 2004;192:503–507.
  • Ziedonis DM, Rayford BS, Bryant KJ, Rounsaville BJ. Psychiatric comorbidity in white and African-American cocaine addicts seeking substance abuse treatment. Hosp Community Psychiatry. 1994;45:43–49.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.